Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...
In 2024, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and ...
Ottawa Citizen on MSN22h
Why a 91-year-old Ottawa man paid $550 for vaccines that should have been freeWhen Canada’s National Advisory Committee on Immunization recommended the new RSV (respiratory syncytial virus) vaccine ...
We aim to build confidence in the safety and reliability of payment service providers’ services while protecting end users from specific risks. We’re taking steps to better understand the impacts of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback